D.E. Shaw & Co
BNR

D.E. Shaw & Co’s Burning Rock Biotech BNR Stock Holding History

D.E. Shaw & Co’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,033
Closed -$19.7K – 4332
2023
Q3 		$19.7K Hold
2,033
– – ﹤0.01% 3989
2023
Q2 		$44.3K Hold
2,033
– – ﹤0.01% 3890
2023
Q1 		$57.1K Sell
2,033
-860
-30% -$25.8K ﹤0.01% 4030
2022
Q4 		$65.1K Sell
2,893
-863
-23% -$19.7K ﹤0.01% 4412
2022
Q3 		$90K Sell
3,756
-14,998
-80% -$484K ﹤0.01% 4613
2022
Q2 		$546K Buy
+18,754
New +$837K ﹤0.01% 4041
2021
Q4 		– Sell
-4,156
Closed -$743K – 5409
2021
Q3 		$743K Buy
+4,156
New +$924K ﹤0.01% 3822
2021
Q2 		– Sell
-1,249
Closed -$336K – 4756
2021
Q1 		$336K Buy
+1,249
New +$380K ﹤0.01% 3663
2020
Q4 		– Sell
-1,068
Closed -$268K – 3922
2020
Q3 		$268K Buy
+1,068
New +$253K ﹤0.01% 3494

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

D.E. Shaw & Co's BNR Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Burning Rock Biotech (BNR) in Q4 2023, closing a stake of 2,033 shares — an estimated $19.7K sold.

D.E. Shaw & Co first reported a position in BNR in Q3 2020 and held it in 9 quarters. The position peaked at $743K in Q3 2021. 19 funds tracked by Wall St. Rank hold BNR as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Burning Rock Biotech position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,033 Burning Rock Biotech shares in Q4 2023, an estimated $19.7K.
  • D.E. Shaw & Co first reported a position in Burning Rock Biotech in Q3 2020 and held it in 9 quarters.
  • D.E. Shaw & Co's Burning Rock Biotech position peaked at $743K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.